SONX (Sonendo) Risk Assessment

View and export this data going back to 2021. Start your Free Trial

What is Sonendo Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Sonendo is: No Data: Cannot be evaluated.

Competitive Comparison of Sonendo's Risk Assessment

For the Medical Devices subindustry, Sonendo's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sonendo's Risk Assessment Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sonendo's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Sonendo's Risk Assessment falls into.

Sonendo (OTCPK:SONX) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Sonendo Risk Assessment Related Terms

Thank you for viewing the detailed overview of Sonendo's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Sonendo Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sonendo Inc (OTCPK:SONX) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

26061 Merit Circle, Suite 102, Laguna Hills, CA, USA, 92653

Website

https://www.sonendo.com

Sonendo Inc is a commercial-stage medical technology company focused on saving teeth from tooth decay, the prevalent chronic disease globally. It has developed the GentleWave System, a technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The Company operates in two business segments, Product segment which derives key revenue, and Software. Product segment includes sales of the Company's GentleWave System console and related accessories and instruments. Software segment includes sales of the Company's traditional software licenses for practice management software to enable an integrated digital office for endodontists.

Executives

Bjarne Bergheim	director, officer: President and CEO	C/O SONENDO, INC., 2601 MERIT CIRCLE, SUITE 102, LAGUNA HILLS CA 92653
Roy T Chen	officer: Chief Talent Officer	C/O SONENDO, INC., 2601 MERIT CIRCLE, SUITE 102, LAGUNA HILLS CA 92653
Olav Bergheim	director, 10 percent owner	ONE PALMER SQUARE, PRINCETON NJ 08542
Pudipeddi Vamsi Mohan Raj	director	2820 ORCHARD PARKWAY, SAN JOSE CA 95134
Michael Patrick Watts	officer: Chief Financial Officer	C/O SONENDO, INC., 2601 MERIT CIRCLE, SUITE 102, LAGUNA HILLS CA 92653
Michael John Smith	officer: Chief Commercial Officer	C/O SONENDO, INC., 2601 MERIT CIRCLE, SUITE 102, LAGUNA HILLS CA 92653
Andrew J Kirkpatrick	officer: Chief Operating Officer	1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
General Atlantic, L.p.	director, 10 percent owner	55 EAST 52ND STREET, 33RD FLOOR, NEW YORK NY 10055
Bihl Anthony P Iii	director	807 SMITH RIDGE ROAD, NEW CANAAN CT 06840
Mehrezad Khakpour	officer: Chief Technology Officer	C/O SONENDO, INC., 2601 MERIT CIRCLE, SUITE 102, LAGUNA HILLS CA 92653
Jacqueline Arnold Collins	officer: VP, General Counsel	C/O SONENDO, INC., 2601 MERIT CIRCLE, SUITE 102, LAGUNA HILLS CA 92653
Carolyn Beaver	director	3595 JOHN HOPKINS COURT, SAN DIEGO CA 92121
General Atlantic (soi), L.p.	10 percent owner	C/O GENERAL ATLANTIC SERVICE COMPANY, LP, 55 EAST 52ND STREET, 33RD FLOOR, NEW YORK NY 10055
General Atlantic Partners (bermuda) Eu, L.p.	10 percent owner	C/O GENERAL ATLANTIC SERVICE COMPANY LP, 55 EAST 52ND STREET, 33RD FLOOR, NEW YORK NY 10055
Gap Coinvestments V, Llc	10 percent owner	55 EAST 52ND STREET, 33RD FLOOR, NEW YORK NY 10055